levodopa has been researched along with carbamazepine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Giralt, E; Malakoutikhah, M; Teixidó, M | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Pynnönen, S; Syvälahti, E | 1 |
| Chadwick, D; Driver, MV; Jenner, P; Reynolds, EH; Trimble, M | 1 |
| Chokroverty, S; Hening, WA; Walters, AS | 1 |
| Christison, GW; Kirch, DG; Wyatt, RJ | 1 |
| Bakchine, S; Benoit, N; Chain, F; Lacomblez, L; Lhermitte, F; Parisot, D | 1 |
| Lee, MC | 1 |
| D'Arcy, PF | 1 |
| Garg, BP | 1 |
| Aderbauer, J; Bock, E; Eilles, C; Fiedler, A; Marienhagen, J; Segerer, H | 1 |
| Dhanuka, AK; Singh, G | 1 |
| Du, L; Lei, F; Li, Y; Sun, Y; Tang, X; Yang, L | 1 |
2 review(s) available for levodopa and carbamazepine
| Article | Year |
|---|---|
Review and videotape recognition of idiopathic restless legs syndrome.
Topics: Anti-Anxiety Agents; Arousal; Baclofen; Benzodiazepines; Bromocriptine; Carbamazepine; Clonidine; Humans; Levodopa; Narcotics; Restless Legs Syndrome; Sleep Stages; Videotape Recording | 1991 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
3 trial(s) available for levodopa and carbamazepine
| Article | Year |
|---|---|
Manipulation of cerebral monoamines in the treatment of human epilepsy: a pilot study.
Topics: Adult; Biogenic Amines; Brain Chemistry; Carbamazepine; Drug Evaluation; Epilepsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Monoamine Oxidase Inhibitors; Pilot Projects; Serotonin; Tryptophan | 1978 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
Manic-like state after bilateral orbitofrontal and right temporoparietal injury: efficacy of clonidine.
Topics: Adult; Behavior; Bipolar Disorder; Brain; Carbamazepine; Clonidine; Cognition; Female; Frontal Lobe; Humans; Levodopa; Orbit; Parietal Lobe; Temporal Lobe; Tomography, X-Ray Computed | 1989 |
20 other study(ies) available for levodopa and carbamazepine
| Article | Year |
|---|---|
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries.
Topics: Biological Transport; Blood-Brain Barrier; Cell Survival; Drug Carriers; Humans; Levodopa; Membranes, Artificial; Peptide Library; Peptides; Permeability; Phenylalanine; Solubility | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Secretion of human growth hormone and insulin in levodopa test during carbamazepine therapy.
Topics: Administration, Oral; Blood Glucose; Carbamazepine; Growth Hormone; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Levodopa; Male; Pituitary Gland; Pituitary Gland, Anterior; Time Factors | 1977 |
General discussion of drug therapy in dystonia.
Topics: Adolescent; Age Factors; Baclofen; Cannabis; Carbamazepine; Child; Child, Preschool; Dystonia Musculorum Deformans; Female; Haloperidol; Humans; Levodopa; Male; Phytotherapy; Torticollis | 1976 |
Spasmodic torticollis and other idiopathic torsion dystonias. Medical management.
Topics: Adrenergic Agents; Amantadine; Antipsychotic Agents; Apomorphine; Benzodiazepines; Carbamazepine; Dystonia; Humans; Levodopa; Parasympatholytics; Torsion Abnormality; Torticollis | 1984 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Dystonia musculorum deformans: implications of therapeutic response to levodopa and carbamazepine.
Topics: Adult; Carbamazepine; Dystonia Musculorum Deformans; Female; Humans; Levodopa; Male | 1982 |
Follow-up findings in regional cerebral blood flow (r-CBF)-SPECT in a case of idiopathic childhood hemidystonia. Functional neuroimaging and pathophysiological implications.
Topics: Anticonvulsants; Brain; Carbamazepine; Cerebrovascular Circulation; Child; Dystonia; Female; Follow-Up Studies; Functional Laterality; Humans; Levodopa; Magnetic Resonance Imaging; Radiopharmaceuticals; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |
Periodic limb movement disorder : a clinical and polysomnographic study.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Carbidopa; Clonazepam; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Polysomnography; Retreatment | 2001 |
Follow-up management of refractory continuous positive airway pressure therapy: emergent periodic limb movements in sleep.
Topics: Benserazide; Carbamazepine; Continuous Positive Airway Pressure; Disorders of Excessive Somnolence; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Polysomnography; Sleep Apnea, Obstructive | 2014 |